News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,932 Results
Type
Article (88216)
Company Profile (823)
Press Release (784872)
Multimedia
Podcasts (208)
Webinars (32)
Section
Business (233358)
Career Advice (4152)
Deals (39899)
Drug Delivery (159)
Drug Development (91488)
Employer Resources (205)
FDA (18448)
Job Trends (17442)
News (398161)
Policy (39998)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3024)
Academic (2)
Accelerated approval (41)
Adcomms (37)
Allergies (166)
Alliances (56982)
ALS (194)
Alzheimer's disease (1829)
Antibody-drug conjugate (ADC) (382)
Approvals (18649)
Artificial intelligence (691)
Autoimmune disease (209)
Automation (48)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (177)
Brain cancer (70)
Breast cancer (703)
Cancer (5393)
Cardiovascular disease (481)
Career advice (3580)
Career pathing (44)
CAR-T (320)
CDC (68)
Celiac Disease (2)
Cell therapy (879)
Cervical cancer (41)
Clinical research (77507)
Collaboration (1979)
Company closure (6)
Compensation (1257)
Complete response letters (84)
COVID-19 (3005)
CRISPR (110)
C-suite (980)
Cystic fibrosis (157)
Data (6777)
Decentralized trials (2)
Denatured (77)
Depression (167)
Diabetes (556)
Diagnostics (7339)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (336)
Drug pricing (231)
Drug shortages (36)
Duchenne muscular dystrophy (266)
Earnings (100842)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135983)
Executive appointments (1077)
FDA (21849)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (13)
Frontotemporal dementia (26)
Funding (1660)
Gene editing (234)
Generative AI (71)
Gene therapy (726)
GLP-1 (1176)
Government (5487)
Grass and pollen (8)
Guidances (389)
Healthcare (20986)
HIV (76)
Huntington's disease (56)
IgA nephropathy (90)
Immunology and inflammation (312)
Immuno-oncology (77)
Indications (137)
Infectious disease (3328)
Inflammatory bowel disease (219)
Inflation Reduction Act (17)
Influenza (135)
Intellectual property (269)
Interviews (817)
IPO (17972)
IRA (61)
Job creations (5202)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (100)
Layoffs (664)
Leadership (44)
Legal (10168)
Liver cancer (102)
Longevity (22)
Lung cancer (720)
Lymphoma (398)
Machine learning (49)
Management (66)
Manufacturing (938)
MASH (186)
Medical device (15101)
Medtech (15169)
Mergers & acquisitions (23056)
Metabolic disorders (1499)
mRNA (202)
Multiple sclerosis (181)
NASH (23)
Neurodegenerative disease (392)
Neuropsychiatric disorders (110)
Neuroscience (3273)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5124)
Now hiring (70)
Obesity (736)
Opinion (350)
Ovarian cancer (177)
Pain (236)
Pancreatic cancer (256)
Parkinson's disease (323)
Partnered (39)
Patents (552)
Patient recruitment (564)
Peanut (65)
People (67204)
Pharmaceutical (144)
Pharmacy benefit managers (34)
Phase 1 (23943)
Phase 2 (33635)
Phase 3 (25339)
Pipeline (6299)
Policy (360)
Postmarket research (3554)
Preclinical (10734)
Press Release (72)
Prostate cancer (275)
Psychedelics (61)
Radiopharmaceuticals (319)
Rare diseases (1034)
Real estate (7445)
Recruiting (81)
Regulatory (29408)
Reports (69)
Research institute (2747)
Resumes & cover letters (653)
Rett syndrome (31)
RNA editing (21)
RSV (91)
Schizophrenia (166)
Series A (280)
Series B (207)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4340)
State (2)
Stomach cancer (21)
Supply chain (121)
Tariffs (101)
The Weekly (129)
Vaccines (1196)
Venture capital (103)
Weight loss (502)
Women's health (107)
Worklife (23)
Date
Today (158)
Last 7 days (755)
Last 30 days (3159)
Last 365 days (32848)
2026 (6248)
2025 (33228)
2024 (38138)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (356)
Arkansas (15)
Asia (51723)
Australia (9088)
California (12318)
Canada (3504)
China (1248)
Colorado (520)
Connecticut (539)
Delaware (366)
Europe (119036)
Florida (1830)
Georgia (398)
Hawaii (4)
Idaho (68)
Illinois (1030)
India (82)
Indiana (578)
Iowa (24)
Japan (473)
Kansas (135)
Kentucky (49)
Louisiana (38)
Maine (85)
Maryland (1528)
Massachusetts (9048)
Michigan (381)
Minnesota (695)
Mississippi (7)
Missouri (147)
Montana (37)
Nebraska (30)
Nevada (136)
New Hampshire (88)
New Jersey (3312)
New Mexico (33)
New York (3245)
North Carolina (1695)
North Dakota (10)
Northern California (5969)
Ohio (379)
Oklahoma (23)
Oregon (55)
Pennsylvania (2452)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (71)
South Dakota (1)
Southern California (4774)
Tennessee (196)
Texas (1943)
United States (44319)
Utah (371)
Vermont (1)
Virginia (311)
Washington D.C. (88)
Washington State (1018)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
There are 873,932 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hemostemix Leadership Attending Abundance360 Summit
March 9, 2026
·
7 min read
Obesity
AbbVie’s Amylin Candidate ‘Competitive’ in Early-Stage Trial
AbbVie’s foray into the obesity space is successful so far, analysts agree, as amylin analog ABBV-295 elicited as much as 9.73% weight loss at 13 weeks in the multiple ascending dose portion of a Phase 1 trial.
March 9, 2026
·
2 min read
·
Heather McKenzie
GLP-1s
Novo Nordisk Agrees To Sell GLP-1 Drugs Via Hims & Hers, Ending Dispute
The companies have been embroiled in a row about compounded GLP-1 drugs that escalated to a lawsuit last month. The legal action has now been dropped and the former adversaries have struck a deal that could increase access to Novo’s obesity medicines.
March 9, 2026
·
2 min read
·
Nick Paul Taylor
Weight loss
Regeneron’s Weight Loss Partner Hansoh Delivers Much-Needed Phase 3 Win in China
Hansoh’s olatorepatide achieved 19% weight loss at 48 weeks in a Phase 3 trial in China, handing partner Regeneron a glimmer of hope for a pipeline in desperate need of reinvigoration.
March 9, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Ministerial Visit to Athlone Laboratories: A Vision for the Future of Critical Medicines in Ireland
March 9, 2026
·
1 min read
Press Releases
CORRECTING & REPLACING -- MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
March 9, 2026
·
7 min read
Press Releases
VS3 Medical Announces First Patients Enrolled in First-in-Human Study of Novel Neurovascular Implant to Address Symptomatic Venous Sinus Stenosis
March 9, 2026
·
3 min read
Press Releases
GE HealthCare announces U.S. FDA 510(k) clearance for View, a next‑generation diagnostic viewer enabling anywhere‑access to radiologists
March 9, 2026
·
3 min read
Press Releases
BrightSpec and Restek Announce Launch of SpectrAline™ Cartridges, a High-Performance Sample Introduction Solution for Molecular Rotational Resonance (MRR)
March 9, 2026
·
2 min read
Press Releases
AnovoRx Appoints Steve Fitzpatrick as Chief Executive Officer
March 9, 2026
·
2 min read
1 of 87,394
Next
